A molecular basis for agonist and antagonist actions at GABAC receptors

Chemical Biology and Drug Design

Volumn 71, Issue 4, 2008, Pages 306-327

  Abdel Halim, Heba ^a   Hanrahan, Jane R ^a   Hibbs, David E ^a   Johnston, Graham A R ^b   Chebib, Mary ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Channel gating; Homology modelling; Ligand docking; Ligand gated ion channels; 1 GABAC receptors

Indexed keywords

1 IMIDAZOLE 4 ACETIC ACID; 1,2,5,6 TETRAHYDROPYRIDINE 4 YL ETHYLPHOSPHINIC ACID; 1,2,5,6 TETRAHYDROPYRIDINE 4 YL METHYLPHOSPHINIC ACID; 2 AMINOMETHYLCYCLOPROPANE 1 CARBOXYLIC ACID; 2 AMINOMETHYLCYCLOPROPANE CARBOXYLIC ACID; 3 AMINO CYCLOBUTYL METHYLPHOSPHINIC ACID; 3 AMINOCYCLOPENTANE CARBOXYLIC ACID; 3 AMINOCYCLOPENTANECARBOXYLIC ACID; 3 AMINOCYCLOPENTANYL METHYLPHOSPHINIC ACID; 3 AMINOCYCLOPENTYL BUTYL PHOSPHINIC ACID; 3 AMINOCYCLOPENTYL METHYLPHOSPHINIC ACID; 3 AMINOPROPYL METHYL PHOSPHINIC ACID; 4 AMINO 2 CYCLOPENTENE 1 CARBOXYLIC ACID; 4 AMINO 2 FLUOROBUTANOIC ACID; 4 AMINO 2 METHYLBUTYRIC ACID; 4 AMINO 2 METHYLENEBUTANOIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID C RECEPTOR; 4 AMINOBUTYRIC ACID C RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID C RECEPTOR STIMULATING AGENT; 4 AMINOCROTONIC ACID; 4 AMINOCYCLOHEX 1 ENE 1 CARBOXYLIC ACID; 4 AMINOCYCLOPENT 1 BUTYL PHOSPHINIC ACID; 4 AMINOCYCLOPENT 1 METHYLPHOSPHINIC ACID; 4 AMINOSULPHONIC ACID; 5 AMINOMETHYL 3 HYDROXY ISAXAZOLE; ACETYLCHOLINE; AMINOCYCLOPENT 1 ENE 1 CARBOXYLIC ACID; AMINOCYCLOPENTANYL METHYLPHOSPHINIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CALCULATION; CONFORMATION; CRYSTAL STRUCTURE; HYDROGEN BOND; LIGAND BINDING; LYMNAEA; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTUM MECHANICS; VALIDATION PROCESS;

LYMNAEA STAGNALIS;

EID: 40449130825     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00642.x     Document Type: Article

References (68)

1. 1 Chebib M., Johnston G.A. (2000) GABA‐Activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem ; 43: 1427–1447.
2. 2 Johnston G.A., Chebib M., Hanrahan J.R., Mewett K.N. (2003) GABA(C) receptors as drug targets. Curr Drug Targets CNS Neurol Disord ; 2: 260–268.
3. 3 Hucho F., Tsetlin V.I., Machold J. (1996) The emerging three‐dimensional structure of a receptor. The nicotinic acetylcholine receptor. Eur J Biochem ; 239: 539–557.
4. 4 Brejc K., Van Dijk W.J., Klaassen R.V., Schuurmans M., Van Der Oost J., Smit A.B., Sixma T.K. (2001) Crystal structure of an ACh‐binding protein reveals the ligand‐binding domain of nicotinic receptors. Nature ; 411: 269–276.
5. 5 Bianchi M.T., Macdonald R.L. (2001) Agonist trapping by GABAA receptor channels. J Neurosci ; 21: 9083–9091.
6. 6 Chebib M., Johnston G.A. (1999) The ‘ABC’ of GABA receptors: a brief review. Clin Exp Pharmacol Physiol ; 26: 937–940.
7. 7 Corringer P.J., Le Novere N., Changeux J.P. (2000) Nicotinic receptors at the amino acid level. Ann Rev Pharmacol Toxicol ; 40: 431–458.
8. 8 Nowak M., Kolaczkowski M., Pawlowski M., Bojarski A.J. (2006) Homology modeling of the serotonin 5‐HT1A receptor using automated docking of bioactive compounds with defined geometry. J Med Chem ; 49: 205–214.
9. 9 Ernst M., Brauchart D., Boresch S., Sieghart W. (2003) Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience ; 119: 933–943.
10. 10 Joseph B., Moon W.J.H. (1991) Computer design of bioactive molecules: a method for receptor‐based de novo ligand design. Proteins Struct Fun Genet ; 11: 314–328.
11. 11 Arnaud C., Gauthier P., Gottesmann C. (2001) Study of a GABAC receptor antagonist on sleep‐waking behavior in rats. Psychopharmacology (Berl) ; 154: 415–419.
12. 12 Johnston G.A. (2002) Medicinal chemistry and molecular pharmacology of GABA(C) receptors. Curr Top Med Chem ; 2: 903–913.
13. 13 Stone R.A., Liu J., Sugimoto R., Capehart C., Zhu X., Pendrak K. (2003) GABA, experimental myopia, and ocular growth in chick. Invest Ophthalmol Vis Sci ; 44: 3933–3946.
14. 14 Sedelnikova A., Smith C.D., Zakharkin S.O., Davis D., Weiss D.S., Chang Y. (2005) Mapping the rho1 GABA(C) receptor agonist binding pocket. Constructing a complete model. J Biol Chem ; 280: 1535–1542.
15. 15 Amin J., Weiss D.S. (1994) Homomeric rho 1 GABA channels: activation properties and domains. Receptors Channels ; 2: 227–236.
16. 16 Harrison N.J., Lummis S.C. (2006) Locating the carboxylate group of GABA in the homomeric rho GABA(A) receptor ligand‐binding pocket. J Biol Chem ; 281: 24455–24461.
17. 17 Torres V.I., Weiss D.S. (2002) Identification of a tyrosine in the agonist binding site of the homomeric rho1 gamma‐aminobutyric acid (GABA) receptor that when mutated, produces spontaneous opening. J Biol Chem ; 277: 43741–43748.
18. 18 Amin J., Weiss D.S. (1996) Insights into the activation mechanism of rho 1 GABA receptors obtained by coexpression of wild type and activation‐impaired subunits. Proc R Soc B: Biol Sci ; 263: 273–282.
19. 19 Madsen C., Jensen A.A., Liljefors T., Kristiansen U., Nielsen B., Hansen C.P., Larsen M., Ebert B., Bang‐Andersen B., Krogsgaard‐Larsen P., Frolund B. (2007) 5‐Substituted imidazole‐4‐acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma‐aminobutyric acid C receptor agonists. J Med Chem ; 50: 4147–4161.
20. 20 Crittenden D.L., Chebib M., Jordan M.J.T. (2004) Stabilization of zwitterions in solution: gamma‐aminobutyric acid (GABA). J Phys Chem A ; 108: 203–211.
21. 21 Crittenden D.L., Chebib M., Jordan M.J. (2005) Stabilization of zwitterions in solution: GABA analogues. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory ; 109: 4195–4201.
22. 22 Chebib M. (2004) GABAC receptor ion channels. Clin Exp Pharmacol Physiol ; 31: 800–804.
23. 23 Chebib M., Duke R.K., Allan R.D., Johnston G.A. (2001) The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABA(C) receptors. Eur J Pharmacol ; 430: 185–192.
24. 24 Chebib M., Mewett K.N., Johnston G.A. (1998) GABA(C) receptor antagonists differentiate between human rho1 and rho2 receptors expressed in Xenopus oocytes. Eur J Pharmacol ; 357: 227–234.
25. 25 Chebib M., Vandenberg R.J., Froestl W., Johnston G.A. (1997) Unsaturated phosphinic analogues of gamma‐aminobutyric acid as GABA(C) receptor antagonists. Eur J Pharmacol ; 329: 223–229.
26. 26 Chebib M., Vandenberg R.J., Johnston G.A. (1997) Analogues of gamma‐aminobutyric acid (GABA) and trans‐4‐aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists. Br J Pharmacol ; 122: 1551–1560.
27. 27 Krehan D., Frolund B., Ebert B., Nielsen B., Krogsgaard‐Larsen P., Johnston G.A., Chebib M. (2003) Aza‐THIP and related analogues of THIP as GABA C antagonists. Bioorg Med Chem ; 11: 4891–4896.
28. 28 Krehan D., Frolund B., Krogsgaard‐Larsen P., Kehler J., Johnston G.A., Chebib M. (2003) Phosphinic, phosphonic and seleninic acid bioisosteres of isonipecotic acid as novel and selective GABA(C) receptor antagonists. Neurochem Int ; 42: 561–565.
29. 29 Vien J., Duke R.K., Mewett K.N., Johnston G.A., Shingai R., Chebib M. (2002) trans‐4‐Amino‐2‐methylbut‐2‐enoic acid (2‐MeTACA) and (+/‐)‐trans‐2‐aminomethylcyclopropanecarboxylic acid ((+/‐)‐TAMP) can differentiate rat rho3 from human rho1 and rho2 recombinant GABA(C) receptors. Br J Pharmacol ; 135: 883–890.
30. 30 Crittenden D.L., Kumar R.J., Hanrahan J.R., Chebib M., Jordan M.J. (2005) Stabilization of zwitterions in solution: phosphinic and phosphonic acid GABA analogues. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory ; 109: 8398–8409.
31. 31 Crittenden D.L., Park A., Qiu J., Silverman R.B., Duke R.K., Johnston G.A., Jordan M.J., Chebib M. (2006) Enantiomers of cis‐constrained and flexible 2‐substituted GABA analogues exert opposite effects at recombinant GABA(C) receptors. Bioorg Med Chem ; 14: 447–455.
32. 32 Goutman J.D., Calvo D.J. (2004) Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA rho 1 receptor. Br J Pharmacol ; 141: 717–727.
33. 33 Smit A.B., Syed N.I., Schaap D., Van Minnen J., Klumperman J., Kits K.S., Lodder H., Van Der Schors R.C., Van Elk R., Sorgedrager B., Brejc K., Sixma T.K., Geraerts W.P. (2001) A glia‐derived acetylcholine‐binding protein that modulates synaptic transmission. Nature ; 411: 261–268.
34. 34 Celie P.H.N., Van Rossum‐Fikkert S.E., Van Dijk W.J., Brejc K., Smit A.B., Sixma T.K. (2004) Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron ; 41: 907–914.
35. 35 Hansen S., Sulzenbacher G., Huxford T., Marchot P., Taylor P., Bourne Y. (2005) Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. The EMBO J ; 24: 3635–3646.
36. 36 Osolodkin D., Chupakhin V., Palyulin V., Zefirov N. (2007) Modeling and analysis of ligand‐receptor interactions in the GABAC receptor. Dokl Biochem Biophys ; 412: 25–28.
37. 37 Campagna‐Slater V., Weaver D.F. (2007) Molecular modelling of the GABAA ion channel protein. J Mol Graph Model ; 25: 721–730.
38. 38 Cromer B.A., Morton C.J., Parker M.W. (2002) Anxiety over GABA(A) receptor structure relieved by AChBP. Trends Biochem Sci ; 27: 280–287.
39. 39 Ernst M., Bruckner S., Boresch S., Sieghart W. (2005) Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol ; 68: 1291–1300.
40. 40 Harrison N.J., Lummis S.C. (2006) Molecular modeling of the GABA(C) receptor ligand‐binding domain. J Mol Model ; 12: 317–324.
41. 41 O’Mara M., Cromer B., Parker M., Chung S.H. (2005) Homology model of the GABAA receptor examined using Brownian dynamics. Biophys J ; 88: 3286–3299.
42. 42 Sutcliffe M.J., Smeeton A.H., Wo Z.G., Oswald R.E. (1998) Molecular modeling of ligand‐gated ion channels. Methods Enzymol ; 293: 589–620.
43. 43 Armstrong N., Gouaux E. (2000) Mechanisms for activation and antagonism of an AMPA‐sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron ; 28: 165–181.
44. 44 Gao F., Bren N., Burghardt T.P., Hansen S., Henchman R.H., Taylor P., McCammon J.A., Sine S.M. (2005) Agonist‐mediated conformational changes in acetylcholine‐binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem ; 280: 8443–8451.
45. 45 Law R.J., Henchman R.H., McCammon J.A. (2005) Chemical theory and computation special feature: a gating mechanism proposed from a simulation of a human {alpha}7 nicotinic acetylcholine receptor. Proc Natl Acad Sci USA ; 102: 6813–6818.
46. 46 Wagner D.A., Czajkowski C. (2001) Structure and dynamics of the GABA binding pocket: a narrowing cleft that constricts during activation. J Neurosci ; 21: 67–74.
47. 47 Thompson J.D., Higgins D.G., Gibson T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position‐specific gap penalties and weight matrix choice. Nucleic Acids Res ; 22: 4673–4680.
48. 48 Maseras F., Morkuma K. (1995) IMOMM: a new integrated ab initio + molecular mechanics geometry optimization scheme of equilibrium structures and transition states. J Comp Chem ; 16: 1170–1179.
49. 49 Stephens P.J., Devlin F.J., Chabalowski C.F., Frisch M.J. (1994) Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J Phys Chem ; 98: 11623–11627.
50. 50 Lee C., Yang W., Parr R.G. (1988) Development of the Colle–Salvetti correlation‐energy formula into a functional of the electron density. Phys Rev B ; 37: 785–789.
51. 51 Becke A.D. (1993) Density‐functional thermochemistry. III. The role of exact exchange. J Chem Phys ; 98: 5648–5652.
52. 52 Banks J.L, Beard H.S., Cao Y., Cho A.E., Damm W., Farid R., Felts A.K. et al. (2005) Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem ; 26: 1752–1780.
53. 53 Russell R.B., Saqi M.A., Sayle R.A., Bates P.A., Sternberg M.J. (1997) Recognition of analogous and homologous protein folds: analysis of sequence and structure conservation. J Mol Biol ; 269: 423–439.
54. 54 Sander C., Schneider R. (1991) Database of homology‐derived protein structures and the structural meaning of sequence alignment. Proteins Struct Fun Genet ; 9: 56–68.
55. 55 Fiser A., Do R.K., Sali A. (2000) Modeling of loops in protein structures. Protein Sci ; 9: 1753–1773.
56. 56 Levefelt C., Lundh D.A. (2006) Fold‐recognition approach to loop modeling. J Mol Model ; 12: 125–139.
57. 57 Trudell J.R. (2002) Unique assignment of inter‐subunit association in GABAA [alpha]1[beta]3[gamma]2 receptors determined by molecular modeling. Biochim Biophys Acta ; 1565: 91–96.
58. 58 Ramachandran G.N., Ramakrishnan C., Sasisekharan V. (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol ; 7: 95–99.
59. 59 Panigrahi S.K., Desiraju G.R. (2007) Strong and weak hydrogen bonds in the protein‐ligand interface. Proteins ; 67: 128–141.
60. 60 Lummis S.C., Beene D.L., Harrison N.J., Lester H.A., Dougherty D.A. (2005) A cation‐pi binding interaction with a tyrosine in the binding site of the GABAC receptor. Chem Biol ; 12: 993–997.
61. 61 Zhong W., Gallivan J.P., Zhang Y., Li L., Lester H.A., Dougherty D.A. (1998) From ab initio quantum mechanics to molecular neurobiology: a cation‐pi binding site in the nicotinic receptor. Proc Natl Acad Sci USA ; 95: 12088–12093.
62. 62 Crittenden D.L., Chebib M., Jordan M.J.T. (2005) A quantitative structure‐activity relationship investigation into agonist binding at GABAC receptors. J Mol Struct THEOCHEM ; 755: 81–89.
63. 63 Fenalti G., Law R., Buckle A., Langendorf C., Tuck K., Rosado C., Faux N. et al. (2007) GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol ; 14: 280–286.
64. 64 Chang Y., Weiss D.S. (1999) Channel opening locks agonist onto the GABAC receptor. Nat Neurosci ; 2: 219–225.
65. 65 Chang Y., Weiss D.S. (2002) Site‐specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism. Nat Neurosci ; 5: 1163–1168.
66. 66 Sakmann B. (1992) Elementary steps in synaptic transmission revealed by currents through single ion channels. Science ; 256: 503–512.
67. 67 Grosman C., Zhou M., Auerbach A. (2000) Mapping the conformational wave of acetylcholine receptor channel gating. Nature ; 403: 773–776.
68. 68 Henchman R.H., Wang H.‐L., Sine S.M., Taylor P., McCammon J.A. (2003) Asymmetric structural motions of the homomeric {alpha}7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys J ; 85: 3007–3018.